Shanghai Medicilon (SHSE:688202) Accounts Payable & Accrued Expense : ¥251 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon Accounts Payable & Accrued Expense?

Shanghai Medicilon's quarterly accounts payable & accrued expense declined from Jun. 2023 (¥265 Mil) to Sep. 2023 (¥249 Mil) but then increased from Sep. 2023 (¥249 Mil) to Dec. 2023 (¥251 Mil).

Shanghai Medicilon's annual accounts payable & accrued expense increased from Dec. 2021 (¥210 Mil) to Dec. 2022 (¥277 Mil) but then declined from Dec. 2022 (¥277 Mil) to Dec. 2023 (¥251 Mil).

Shanghai Medicilon Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shanghai Medicilon's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon Accounts Payable & Accrued Expense Chart

Shanghai Medicilon Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

80.12

139.46

209.83

277.33

251.41

Shanghai Medicilon Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															277.33	287.97	265.26	249.00	251.41

Shanghai Medicilon Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shanghai Medicilon (SHSE:688202) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website

http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Shanghai Medicilon (SHSE:688202) Headlines

No Headlines